SCHEMBL11564103

SCHEMBL11564103

Cc1nc(N)c(C#N)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14549180 0.78
SCHEMBL8555731 0.78
SCHEMBL17088286 0.76 KDM4E (0.34)
SCHEMBL17547305 0.74
SCHEMBL11583412 0.74
SCHEMBL6845036 0.74
SCHEMBL167563 0.74 LMNA (0.39)
SCHEMBL1514052 0.71 SMN1; SMN2 (0.33)
SCHEMBL9826435 0.71 KDM4E (0.33)
SCHEMBL15305911 0.71 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605154-B2 ATP-protein kinase inhibitors; cytomegalovirus; contraceptive agents; cancer; N7-(3-ethynyl-phenyl)-N2-(4-piperidin-1-ylmethyl-phenyl)-thiazolo[4,5-d]pyrimidine-2,7-diamine JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-20 US disclosed
US-4153607-A Process for the production of 4,5-disubstituted thiazoles BASF AKTIENGESELLSCHAFT (DE) 1979-05-08 US disclosed